Valuation: Terumo Corporation

Market Cap 3,317B 20.27B 17.82B 16.59B 15.23B 28.6B 1,944B 28.98B 197B 77B 960B 76.09B 74.45B P/E 2027 *
19.8x
P/E 2028 * 17.9x
Enterprise Value 3,393B 20.73B 18.23B 16.97B 15.58B 29.26B 1,988B 29.64B 202B 78.77B 982B 77.83B 76.15B EV / Sales 2027 *
2.74x
EV / Sales 2028 * 2.53x
Free-Float
97.07%
Yield 2027 *
1.59%
Yield 2028 * 1.77%
1 day+2.42%
1 week+2.81%
Current month+3.11%
1 month+2.51%
3 months+13.75%
6 months+10.67%
Current year+1.48%
1 week 2,133
Extreme 2133
2,330.5
1 month 2,133
Extreme 2133
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.09%+2.81%-11.06%+1.32% 19.5B
+1.39%+2.78%-17.43%-7.24% 180B
+1.21%+1.12%-9.38%-4.85% 107B
+0.41%+2.36%+7.16%+66.10% 60.29B
-2.24%-4.77%+24.25%+52.47% 50.19B
+1.64%+2.87%-14.25%-43.96% 43.08B
+2.45%+2.11% - - 32.77B
+2.56%-3.07%-17.55%-43.28% 27.61B
+0.93%-5.98%+25.71%-6.66% 23.1B
+2.02%+1.83%-5.23%-4.95% 20.86B
Average +1.30%-2.47%-1.98%+0.99% 56.34B
Weighted average by Cap. +1.13%-0.54%-6.23%+2.79%

Financials

2027 *2028 *
Net sales 1,239B 7.57B 6.65B 6.19B 5.69B 10.68B 726B 10.82B 73.63B 28.76B 358B 28.41B 27.8B 1,318B 8.05B 7.08B 6.59B 6.05B 11.36B 772B 11.51B 78.31B 30.58B 381B 30.22B 29.57B
Net income 166B 1.01B 890M 829M 761M 1.43B 97.11B 1.45B 9.85B 3.85B 47.95B 3.8B 3.72B 185B 1.13B 995M 926M 850M 1.6B 109B 1.62B 11.01B 4.3B 53.59B 4.25B 4.16B
Net Debt 75.98B 464M 408M 380M 349M 655M 44.52B 664M 4.52B 1.76B 21.98B 1.74B 1.71B 16.78B 103M 90.14M 83.91M 77.06M 145M 9.83B 147M 997M 390M 4.86B 385M 377M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
28/07/26 ¥2,295.50 +2.07% 689,300
27/07/26 ¥2,249.00 +3.90% 4,788,800
24/07/26 ¥2,164.50 +0.30% 2,693,400
23/07/26 ¥2,158.00 -1.86% 3,500,500
22/07/26 ¥2,199.00 -1.85% 4,119,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,249.00JPY
Average target price
2,961.54JPY
Spread / Average Target
+31.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock